A patient with systemic lupus erythematosus (SLE) presents with increasing fatigue, facial rash, shortness of breath, chest pain, proteinuria, and microscopic hematuria. Which nursing intervention is a priority for this patient to prevent further complications?

C) Monitor the patient's fluid balance and report any significant changes.

A) Encourage the patient to maintain a high-protein diet to support kidney function.

B) Educate the patient on the importance of rest and avoiding sun exposure.

C) Monitor the patient's fluid balance and report any significant changes.

D) Administer prescribed NSAIDs to manage chest pain effectively.

A patient with systemic lupus erythematosus (SLE) presents with increased fatigue, facial rash, shortness of breath, and chest pain. Laboratory findings reveal elevated anti-dsDNA antibodies, low complement levels, and urine analysis shows proteinuria and microscopic hematuria. Which nursing intervention is most appropriate to address the patient's respiratory symptoms?

A) Encourage the patient to perform incentive spirometry every hour while awake.

B) Position the patient in a supine position to improve lung expansion.

C) Administer prescribed diuretics to reduce pleural effusion.

D) Educate the patient on the importance of daily weight monitoring.

A patient with systemic lupus erythematosus (SLE) is experiencing persistent respiratory symptoms and has developed a new fever. Given the current clinical scenario, what is the most appropriate nursing action to prioritize in this situation?

B) Monitor for signs of infection and report any changes immediately

A) Increase the dosage of prednisone to address inflammation

B) Monitor for signs of infection and report any changes immediately

C) Administer antipyretics to manage the fever

D) Encourage deep breathing exercises to improve respiratory function

A patient with systemic lupus erythematosus (SLE) is experiencing persistent respiratory symptoms, elevated heart rate, and new-onset fever despite an increased prednisone dosage and the addition of hydroxychloroquine. What is the most appropriate nursing action to address the patient's current respiratory distress?

C) Elevate the head of the bed to 45 degrees to facilitate breathing.

A) Encourage deep breathing exercises to improve lung expansion.

B) Monitor urine output closely to assess for fluid retention.

C) Elevate the head of the bed to 45 degrees to facilitate breathing.

D) Administer acetaminophen to manage the fever and reduce discomfort.

A patient with systemic lupus erythematosus (SLE) is being treated with hydroxychloroquine and a low-dose diuretic. Despite improvements in respiratory symptoms, she continues to experience intermittent fevers and elevated inflammatory markers. Her healthcare team is considering the introduction of mycophenolate mofetil. What is the priority nursing assessment following the initiation of mycophenolate mofetil therapy?

A) Monitor for signs of infection due to immunosuppression.

B) Assess for improvement in respiratory symptoms.

C) Check for changes in blood pressure due to diuretic use.

D) Evaluate dietary intake to ensure adequate nutrition.

A patient with systemic lupus erythematosus (SLE) is experiencing a flare characterized by persistent fever, elevated ESR and CRP levels, and mild proteinuria. After initiating hydroxychloroquine and low-dose diuretics, the team considers adding mycophenolate mofetil to her regimen. Which nursing intervention is most critical when initiating mycophenolate mofetil for this patient?

B) Monitoring the patient for signs of infection due to immunosuppression

A) Educating the patient about the importance of adhering to a low-sodium diet

B) Monitoring the patient for signs of infection due to immunosuppression

C) Ensuring the patient receives adequate hydration to prevent renal toxicity

D) Assessing the patient for signs of gastrointestinal distress related to medication

A patient with a history of lupus and recent adjustment in immunosuppressive therapy presents with increased fatigue, joint pain, and mild proteinuria. Which nursing intervention is most appropriate to address the patient's current symptoms and potential complications?

B) Monitor vital signs and report significant changes to the healthcare provider.

A) Encourage the patient to increase physical activity to reduce joint stiffness.

B) Monitor vital signs and report significant changes to the healthcare provider.

C) Advise the patient to take over-the-counter NSAIDs for joint pain relief.

D) Suggest a high-protein diet to address the proteinuria.

A patient with systemic lupus erythematosus (SLE) is experiencing increased fatigue, joint pain, and signs of inflammation despite adjustments to her immunosuppressive therapy. Which nursing intervention is most appropriate to address the current complications and support the patient's condition?

B) Monitor vital signs closely and report any significant changes to the healthcare provider.

A) Encourage increased physical activity to reduce fatigue and improve joint mobility.

B) Monitor vital signs closely and report any significant changes to the healthcare provider.

C) Advise the patient to increase dietary sodium to manage fluctuating blood pressure.

D) Instruct the patient to discontinue mycophenolate mofetil until symptoms resolve.

A patient with lupus nephritis is experiencing a new onset of shortness of breath and persistent cough after an increase in corticosteroid dosage and transition from mycophenolate mofetil to azathioprine. As the nurse, what is the priority action you should take?

B) Notify the healthcare provider immediately about the potential complications

A) Administer oxygen therapy to alleviate respiratory distress

B) Notify the healthcare provider immediately about the potential complications

C) Educate the patient on the side effects of azathioprine

D) Monitor the patient's vital signs for further deterioration

A patient with systemic lupus erythematosus (SLE) is experiencing a lupus nephritis flare and has been started on increased corticosteroids and transitioned to azathioprine. She now presents with shortness of breath and a persistent cough. Which nursing intervention is the priority in this situation?

B) Notify the healthcare provider about the symptoms.

A) Administer supplemental oxygen to the patient.

B) Notify the healthcare provider about the symptoms.

C) Obtain a sputum culture for analysis.

D) Monitor the patient's vital signs and oxygen saturation closely.

systemic lupus - Nursing Case Study

Pathophysiology

• Primary mechanism: Systemic lupus erythematosus (SLE) is an autoimmune disorder where the immune system mistakenly attacks healthy tissues, primarily due to the production of autoantibodies against nuclear components, such as DNA, leading to widespread inflammation and tissue damage.

• Secondary mechanism: Immune complex deposition occurs as these autoantibodies form complexes with nuclear antigens. These complexes deposit in various organs, notably the kidneys, skin, and joints, triggering complement activation and further inflammatory responses.

• Key complication: Kidney involvement, known as lupus nephritis, is a significant complication due to immune complex deposition in the glomeruli, leading to impaired kidney function, proteinuria, and potentially progressing to chronic kidney disease if not managed effectively.

Patient Profile

Demographics:

29, female, teacher

History:

• Key past medical history: Diagnosed with systemic lupus erythematosus (SLE) 3 years ago, history of joint pain and fatigue

• Current medications: Hydroxychloroquine, prednisone, ibuprofen as needed

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Increasing fatigue and facial rash

• Key symptoms: Joint pain in hands and knees, new onset of shortness of breath, occasional chest pain, photosensitivity, oral ulcers

• Vital signs: Blood pressure 145/90 mmHg, heart rate 102 bpm, respiratory rate 22 breaths per minute, temperature 99.1°F, oxygen saturation 94% on room air

Section 1

Following the initial assessment, the patient underwent a comprehensive evaluation to better understand her current condition. Given her increasing fatigue, facial rash, and the new onset of shortness of breath and chest pain, the healthcare team prioritized laboratory tests and imaging studies. The lab results revealed elevated anti-double-stranded DNA (anti-dsDNA) antibodies and low complement levels (C3 and C4), confirming active lupus disease. Additionally, her urine analysis showed significant proteinuria and microscopic hematuria, indicative of possible lupus nephritis. An echocardiogram was performed due to her chest pain and revealed mild pericardial effusion, suggesting pericarditis, a common cardiac manifestation of systemic lupus erythematosus.

The patient's condition progressed with increased shortness of breath, prompting further investigation into her respiratory status. A chest X-ray showed mild bilateral pleural effusions, contributing to her respiratory symptoms. These findings raised concerns about pleuritis, another potential complication of lupus. Given the combination of pericardial and pleural involvement, the care team recognized the need for a multidisciplinary approach to address the overlapping issues and prevent further deterioration.

These developments prompted discussions around adjusting her treatment plan. The healthcare team considered increasing the dosage of prednisone to control the acute inflammatory processes and initiating mycophenolate mofetil as a steroid-sparing agent to manage her systemic disease activity. The team also emphasized the importance of regular follow-up and monitoring for potential renal function decline, given the signs of lupus nephritis. This evolving clinical scenario required careful coordination between rheumatology, nephrology, and cardiology specialties to optimize her management and prevent long-term complications.

Section 2

The patient's response to the newly adjusted treatment regimen was closely monitored over the following week. Initially, there was a modest improvement in her fatigue and facial rash, suggesting some early response to the increased prednisone dosage. However, her respiratory symptoms persisted, with the patient reporting continued shortness of breath and occasional palpitations. Vital signs revealed a respiratory rate of 24 breaths per minute and a heart rate of 110 beats per minute, indicating tachycardia. Blood pressure was slightly elevated at 142/88 mmHg. These findings prompted the healthcare team to re-evaluate her condition, suspecting that her pleural and pericardial involvement might be more extensive than initially assessed.

Further laboratory investigations demonstrated a further decrease in serum complement levels, with C3 at 56 mg/dL (normal range: 90-180 mg/dL) and C4 at 8 mg/dL (normal range: 10-40 mg/dL), suggesting ongoing active lupus disease. A repeat echocardiogram showed a slight increase in the pericardial effusion, raising concerns about the potential for tamponade if left unchecked. In light of these findings, the interdisciplinary team, including a cardiologist, determined that the patient would benefit from a low-dose diuretic to help manage the pleural effusions and alleviate respiratory distress. Additionally, the team decided to initiate hydroxychloroquine, recognizing its long-term benefits in reducing disease flares and potentially stabilizing her condition.

Despite these interventions, the patient developed a new complication: intermittent fever with temperatures peaking at 101.5°F. This new symptom raised suspicions of an infectious process or an exacerbation of systemic inflammation. Blood cultures were drawn, and the patient was started on broad-spectrum antibiotics empirically while awaiting results, given her immunocompromised status due to the current treatment regimen. The healthcare team emphasized the need for vigilant monitoring and swift adaptation of her treatment plan to address these evolving challenges, aiming to prevent further complications and maintain her quality of life. This complex clinical picture required continued collaboration across specialties to refine her management strategy and improve her prognosis.

Section 3

Following the introduction of hydroxychloroquine and the low-dose diuretic, the healthcare team closely monitored the patient's response. Within three days, there was a noticeable improvement in her respiratory symptoms, with the patient's shortness of breath slightly alleviated. Her respiratory rate decreased to 20 breaths per minute, and the heart rate stabilized at 98 beats per minute. However, the fever persisted, and her temperature continued to spike intermittently. Blood culture results returned negative, ruling out a bacterial infection as the source of her fever, suggesting that the fever was likely due to lupus activity or a potential viral infection.

Further laboratory tests were conducted to explore the cause of the persistent fever and systemic inflammation. Her erythrocyte sedimentation rate (ESR) was elevated at 60 mm/hr (normal range: 0-20 mm/hr), and C-reactive protein (CRP) levels were high at 45 mg/L (normal range: <10 mg/L), indicating significant inflammatory activity. Additionally, urinalysis revealed mild proteinuria, with a protein level of 300 mg/24 hours, hinting at possible renal involvement. Given these findings, the healthcare team, including a rheumatologist and nephrologist, considered adjusting her immunosuppressive therapy to better control the systemic inflammation and prevent further organ damage.

As the team evaluated the next steps, they discussed increasing her immunosuppressive regimen with a cautious introduction of mycophenolate mofetil, aiming to address both her systemic symptoms and emerging renal involvement. The interdisciplinary approach remained pivotal to her care, as the team continued to balance the risks of potent immunosuppression against the need to mitigate her lupus flare. The plan involved regular follow-up assessments and laboratory monitoring to ensure that her condition stabilized while minimizing potential side effects, ultimately striving to enhance her overall quality of life.

Section 4

Despite the adjustments to the patient's immunosuppressive therapy, within a week, new complications began to emerge. The patient started experiencing increased fatigue and joint pain, particularly in her wrists and knees, which were not present prior to the adjustment. Upon physical examination, these joints were noted to be mildly swollen and tender, suggestive of an inflammatory response. Her vital signs showed a slight increase in respiratory rate to 22 breaths per minute, and her heart rate climbed to 105 beats per minute, indicating potential hemodynamic stress. Additionally, her blood pressure was noted to fluctuate, ranging from 110/70 mmHg to 140/90 mmHg, prompting further investigation into possible underlying causes.

Laboratory tests were repeated to assess her current status. Her ESR and CRP levels showed a slight increase, with ESR rising to 70 mm/hr and CRP to 50 mg/L, indicating persistent or worsening inflammation. A repeat urinalysis showed a slight increase in proteinuria, now measuring 450 mg/24 hours, raising concerns about progressive renal involvement. The healthcare team discussed the possibility of mycophenolate mofetil contributing to the patient's symptoms and considered whether the dosage might need adjustment or if alternative therapies should be explored. They also contemplated whether the current lupus flare was not adequately controlled or if the patient was developing a secondary condition.

In light of these developments, the interdisciplinary team decided to conduct further diagnostic imaging, including a renal ultrasound, to evaluate for structural changes or complications such as nephritis. Additionally, they planned for a comprehensive rheumatologic panel to reassess her autoimmune markers, aiming to better understand the disease activity and adjust her treatment plan accordingly. The team emphasized the importance of a balanced approach, carefully adjusting her medications to control the lupus flare while minimizing adverse effects, and maintaining close monitoring to promptly address any new or worsening symptoms.

Section 5

Following the interdisciplinary team's decision to perform a renal ultrasound and comprehensive rheumatologic panel, the results provided further insight into the patient's condition. The renal ultrasound revealed mild bilateral renal enlargement with increased echogenicity, suggestive of active lupus nephritis. These findings correlated with the patient's worsening proteinuria and pointed towards a need for more aggressive management of her renal involvement. The comprehensive rheumatologic panel showed elevated anti-double-stranded DNA (anti-dsDNA) antibodies and low complement levels, reinforcing the suspicion of an active lupus flare.

In response to these findings, the healthcare team convened to reassess the patient's treatment plan. They decided to increase her corticosteroid dosage temporarily to address the acute flare, while also considering a transition from mycophenolate mofetil to another immunosuppressive agent such as azathioprine, aiming to better control her symptoms and reduce the risk of further renal damage. To support her treatment plan and minimize complications, the team scheduled regular follow-ups to closely monitor her renal function, inflammation markers, and overall clinical status.

Despite these adjustments, the patient began experiencing new complications over the next few days. She developed shortness of breath and a persistent cough, prompting concerns about potential pulmonary involvement or an opportunistic infection, given her immunosuppressed state. A chest X-ray was ordered to evaluate for any signs of pleural effusion or infection. The patient's fluctuating blood pressure and increased heart rate necessitated further cardiac assessment to rule out lupus-related cardiac involvement. These developments underscored the complexity of her condition, requiring ongoing clinical vigilance and a multi-faceted approach to her care.